Migard frovatriptan: Began Phase IIIb/IV clinical trials

(Elan deal modified, B4)

Vernalis Group plc (LSE:VER), Guildford, U.K.
Product: Migard

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE